[go: up one dir, main page]

NO20005588D0 - Inhibisjon av Helicobacter Pylori proliferasjon - Google Patents

Inhibisjon av Helicobacter Pylori proliferasjon

Info

Publication number
NO20005588D0
NO20005588D0 NO20005588A NO20005588A NO20005588D0 NO 20005588 D0 NO20005588 D0 NO 20005588D0 NO 20005588 A NO20005588 A NO 20005588A NO 20005588 A NO20005588 A NO 20005588A NO 20005588 D0 NO20005588 D0 NO 20005588D0
Authority
NO
Norway
Prior art keywords
inhibition
helicobacter pylori
pylori proliferation
proliferation
helicobacter
Prior art date
Application number
NO20005588A
Other languages
English (en)
Other versions
NO20005588L (no
Inventor
Hiroshi Kaneko
Terunori Mitsuma
Koichi Yamashita
Barry A Morgan
Original Assignee
Sod Conseils Rech Applic
Hiroshi Kaneko
Terunori Mitsuma
Koichi Yamashita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Hiroshi Kaneko, Terunori Mitsuma, Koichi Yamashita filed Critical Sod Conseils Rech Applic
Publication of NO20005588D0 publication Critical patent/NO20005588D0/no
Publication of NO20005588L publication Critical patent/NO20005588L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20005588A 1998-05-07 2000-11-06 Inhibisjon av Helicobacter Pylori proliferasjon NO20005588L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/074,117 US5968903A (en) 1998-05-07 1998-05-07 Inhibition of H. pylori proliferation
PCT/US1999/010058 WO1999056769A2 (en) 1998-05-07 1999-05-06 Inhibition of helicobacter pylori proliferation

Publications (2)

Publication Number Publication Date
NO20005588D0 true NO20005588D0 (no) 2000-11-06
NO20005588L NO20005588L (no) 2001-01-05

Family

ID=22117835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005588A NO20005588L (no) 1998-05-07 2000-11-06 Inhibisjon av Helicobacter Pylori proliferasjon

Country Status (6)

Country Link
US (1) US5968903A (no)
EP (1) EP1075273A2 (no)
JP (1) JP2002513769A (no)
AU (1) AU3975499A (no)
NO (1) NO20005588L (no)
WO (1) WO1999056769A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4099065B2 (ja) * 2001-01-12 2008-06-11 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス 血管増殖を阻害する医薬組成物とその使用の方法
DE60232203D1 (de) * 2001-03-06 2009-06-10 Il Consorzio Ferrara Richerche Verfahren zur Modulation der Proliferation von Schilddrüsenkrebszellen
US7514406B2 (en) * 2001-11-27 2009-04-07 Fred Hutchinson Cancer Research Center Methods for inhibiting deacetylase activity
US7122622B2 (en) * 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
CA2546448A1 (en) * 2003-11-25 2005-06-16 Novartis Ag Biomarkers for the efficacy of somatostatin analogue treatment
CN107446053A (zh) 2008-06-12 2017-12-08 益普生生物创新有限公司 癌症的抑制
EP2719392B1 (en) 2008-06-12 2019-07-24 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4133782A (en) * 1976-06-07 1979-01-09 The Salk Institute For Biological Studies Somatostatin analogs with dissociated biological activities
US4190575A (en) * 1977-12-27 1980-02-26 American Home Products Corporation Polypeptides related to somatostatin
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
DK153293C (da) * 1977-07-22 1988-11-14 Stamicarbon Katalysator til dehydrogenering af organiske forbindelser, isaer aminer, thioler og alkoholer, og fremgangsmaade til fremstilling deraf
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
CA1107273A (en) * 1978-05-19 1981-08-18 Chester A. Meyers Somatostatin analogs having a substituted tryptophyl residue in position eight
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
US4215039A (en) * 1979-02-15 1980-07-29 American Home Products Corporation Somatostatin analogues
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4316890A (en) * 1979-03-16 1982-02-23 Ciba-Geigy Corporation Peptides and processes for the manufacture thereof
US4209426A (en) * 1979-05-29 1980-06-24 American Home Products Corporation Polypeptides related to somatostatin
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
EP0031303A3 (de) * 1979-12-21 1981-11-04 Ciba-Geigy Ag Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
ATE14226T1 (de) * 1981-12-24 1985-07-15 Ciba Geigy Ag Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
FR2522655B1 (fr) * 1982-03-05 1987-03-06 Sanofi Sa Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
US4486415A (en) * 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
WO1989007109A1 (en) * 1988-02-01 1989-08-10 The Upjohn Company Renin inhibiting peptides with polar end groups
NO893088L (no) * 1988-08-18 1990-02-19 Syntex Inc Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
CA2012115C (en) * 1989-03-15 2001-07-03 Biomeasure, Inc. Iodinated somatostatins
KR0173119B1 (ko) * 1989-04-26 1999-02-01 닐 에이. 밴스로우 선형 소마토스타틴 유사체
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
DE69435105D1 (de) * 1993-08-09 2008-08-07 Sod Conseils Rech Applic Derivate therapeutischer Peptide
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
AU3215597A (en) * 1996-08-30 1998-03-19 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
WO1998010786A2 (en) * 1996-09-12 1998-03-19 Yarom Cohen Pharmaceutical composition for the treatment of syndrome x of reaven

Also Published As

Publication number Publication date
NO20005588L (no) 2001-01-05
EP1075273A2 (en) 2001-02-14
WO1999056769A3 (en) 2000-11-09
US5968903A (en) 1999-10-19
JP2002513769A (ja) 2002-05-14
AU3975499A (en) 1999-11-23
WO1999056769A2 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
NO20001708D0 (no) Fremgangsmåte for beskyttelse av overførte data
FI980732A0 (fi) Foerfarande foer koppling av dataoeverfoeringsstroemmar
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
FI980343A0 (fi) Foerfarande foer kontrollering av effekt
FI980783A0 (fi) Foerfarande foer utformning av en signaleringsfoerbindelse
DE19980536D2 (de) Vinylen- und Ethylverbindungen
NO20010899L (no) Forbedring av ugunstige apomorfin-effekter
NO981305D0 (no) Utblåsningssikring
FI980465A0 (fi) Foerfarande foer installering av tjaenster
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20005588D0 (no) Inhibisjon av Helicobacter Pylori proliferasjon
GB0017239D0 (en) Detection of helicobacter pylori
FI980150A0 (fi) Foerfarande foer oeverfoering av bildinformation
DE69915988D1 (de) Inhibitor der Koloniebildung von Helicobacter pylori
IS5771A (is) Fyrirbygging á endurteknu mígreni
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20006262D0 (no) Fôring av rör
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
FI980044A0 (fi) Foerfarande foer behandling av en fiberbana
ID23647A (id) Komposisi-komposisi herbisida baru
EE200000572A (et) Konstruktsioon seadmete omavaheliseks mehaaniliseks lukustamiseks
FI980095A0 (fi) Foerfarande foer byggande av fartyg
NO985089D0 (no) Merking av gjenstander
KR980005707U (ko) 변조기의 비트 방지회로
ATA87999A (de) Isolier- und abdichtungsbahn

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application